• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 14, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home BIOENGINEERING

Study: Access to long-lasting contraception after childbirth lags behind demand

Bioengineer by Bioengineer
February 9, 2018
in BIOENGINEERING
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: University of Michigan Institute for Healthcare Policy and Innovation

ANN ARBOR, Mich. – Before leaving the hospital after childbirth, more women are opting to check one thing off their list: birth control.

But access to long-lasting, reversible contraception like an intrauterine device immediately after giving birth may still lag far behind the demand, a new University of Michigan study suggests.

The rate of IUDs or implants after childbirth increased sevenfold over five years — from 1.86 per 10,000 deliveries in 2008 to 13.5 per 10,000 deliveries in 2013 — according to the findings in Obstetrics & Gynecology.

Some 96 percent of inpatient postpartum IUDs, however, are placed at urban teaching hospitals, suggesting that the service is not available to women delivering at urban non-teaching and rural hospitals.

Overall, the rate of patients receiving reversible contraception while hospitalized for a delivery still remained less than 2 percent of the sterilization rate (a permanent procedure to prevent pregnancy.)

"Getting an IUD right after childbirth may be more convenient and less painful than insertion at a later office visit. But we found that access to this service varies greatly depending on where a woman delivers her baby," says lead author Michelle Moniz, M.D. M.Sc., an assistant professor of obstetrics and gynecology and researcher at the University of Michigan Medical School.

"Maternity clinicians and policymakers should strive to ensure that women have access to the full range of contraceptive options after childbirth and that they are able to make an informed, voluntary, personal choice about whether and when to have another child."

Unintended, repeat pregnancy too close to the birth of a first baby can be dangerous for both moms and babies, with higher likelihood of adverse outcomes such as miscarriage, preterm labor and stillbirth.

Enhancing access to in-hospital reversible contraception and insurance coverage for the service will help prevent such unintended pregnancies, Moniz says. Women using highly effective contraception — including IUDs, implants or tubal sterilization — are four times more likely to achieve adequate birth spacing than women using a barrier or no method. However, few U.S. women use these methods by three months postpartum, partly as a result of poor access.

IUDs inserted immediately after birth have a slightly higher chance of falling out than IUDs inserted four to eight weeks later — but the risk of dangerous complications like infection or injury is exceedingly low with both immediate and delayed placement. Immediate placement is also cost-effective, Moniz says. Contraceptive implants do not have risk of falling out, so they are a particularly attractive option for insertion during the delivery hospitalization.

U-M researchers found that IUD and implant insertions during a maternal hospitalization were more likely among sicker, poorer women delivering at urban teaching hospitals. Eighty-five percent of inpatient postpartum IUDs are provided to women with public or other insurance, including Medicaid, Medicare or self-pay.

Previous studies suggest that many women who say they want an IUD or implant don't make it to a follow-up office appointment to get their preferred method of birth control after having a baby, often due to childcare, transportation and other barriers.

"We know that many women's first choice for birth control is an IUD or implant, which are also the safest and most effective forms of reversible contraception," Moniz says. "We need to remove the barriers that prevent women from getting their preferred method of contraception in a way that's most convenient for them.

"Expanding access to reversible contraception after childbirth will have a far-reaching impact."

###

Media Contact

Beata Mostafavi
[email protected]
734-764-2220
@umichmedicine

http://www.med.umich.edu

Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

Ferrets, cats and civets most susceptible to coronavirus infection after humans

December 10, 2020
IMAGE

Deep Longevity publishes an epigenetic aging clock of unprecedented accuracy

December 8, 2020

How poor oral hygiene may result in metabolic syndrome

December 8, 2020

New findings shed light on the repair of UV-induced DNA damage

December 8, 2020
Please login to join discussion

POPULAR NEWS

  • blank

    Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    317 shares
    Share 127 Tweet 79
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    209 shares
    Share 84 Tweet 52
  • New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    200 shares
    Share 80 Tweet 50
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    141 shares
    Share 56 Tweet 35

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionary HX–MS Experiments Unveil Energetic Insights

Targeting Protein Tyrosine Phosphatases: Mechanisms and Functions

New Microfluidic ‘MISO’ Platform Achieves High-Resolution Cryo-EM Using Minimal Starting Material

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.